NCT05138757 Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy Status COMPLETED Phase PHASE1/PHASE2
NCT04974970 Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy Status TERMINATED Phase PHASE1/PHASE2
NCT04950504 Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy Status TERMINATED Phase PHASE1
NCT04872218 Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy Status COMPLETED Phase PHASE2
NCT04603300 OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut Status COMPLETED Phase PHASE1
NCT04511494 Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT Status ACTIVE_NOT_RECRUITING Phase NA
NCT04415593 High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety Status COMPLETED Phase NA
NCT03907397 Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy Status COMPLETED Phase PHASE2
NCT03881696 Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants Status COMPLETED Phase PHASE3
NCT03859700 Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children Status COMPLETED Phase PHASE3
NCT03793608 Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy Status COMPLETED Phase PHASE2